Life Sciences Products & Reviews

Recombinant Human Bone Morphogenetic Protein 2 (BMP-2), a key regulatory protein that induces bone and cartilage formation, used extensively in orthopedics and stem cell differentiation.

Development of custom mammalian stable cell lines that consistently express your target protein of interest, ideal for long-term research, assay development, and production.

Recombinant Human Apolipoprotein E (ApoE), a key protein in lipid metabolism that plays a central role in cardiovascular health and Alzheimer's disease pathogenesis.

A comprehensive collection of active, recombinant protein kinases, crucial for screening and profiling small molecule inhibitors and studying cellular signaling pathways in disease.

Proteins purified from their natural, endogenous sources, preserving post-translational modifications and complex native structures for biologically relevant research applications.

Professional services for site-specific or random labeling of proteins with a variety of tags, including fluorescent dyes, biotin, enzymes, and isotopes, for detection and tracking.

A specialized selection of high-purity, carrier-free cytokines and growth factors optimized for the robust and reproducible growth and differentiation of 3D organoid models.

High-quality recombinant TGF-β superfamily proteins, including TGF-βs, BMPs, and GDFs, for studying cell growth, differentiation, embryogenesis, and tissue repair.

A diverse range of recombinant proteins and antigens associated with specific physiological or pathological states, supporting discovery, assay development, and diagnostic validation.

A service to identify the RNA targets of RNA-binding proteins (RBPs) on a genome-wide scale, providing insights into post-transcriptional regulatory networks.

Recombinant Human B-cell lymphoma 2 (BCL-2) protein, a key regulator of apoptosis (programmed cell death) and a well-established oncoprotein in many cancers.

Recombinant Human B-cell Antigen Receptor Complex-associated protein alpha chain (CD79A), a essential component of the B-cell receptor (BCR) and a marker for B-cell lineage.

Specialized services for the challenging production of functional, stabilized membrane proteins, including GPCRs, ion channels, and transporters, for structural and drug discovery.

End-to-end custom services for the cloning, expression, and purification of soluble recombinant proteins in various host systems, from gene synthesis to purified protein delivery.

Label-free, real-time analysis of biomolecular interactions to determine binding kinetics (kon, koff), affinity (KD), and specificity with high precision and sensitivity.

Monoclonal and polyclonal antibodies with validated performance for the precise detection of disease biomarkers in a wide range of clinical and research immunoassays.

Custom fermentation and purification services to produce gram to kilogram quantities of recombinant proteins for preclinical, clinical, and commercial applications.

A complete set of recombinant interleukins, key signaling molecules of the immune system, for research in immunology, inflammation, cancer, and therapeutic development.

A specialized protein interaction screening service designed to identify interacting partners for membrane proteins, which are typically difficult to study with conventional Y2H.

A powerful technology platform for screening large libraries of antibodies, peptides, or protein domains displayed on phage to identify high-affinity binders against any target.

A diverse collection of proteins engineered for therapeutic use, including cytokines, growth factors, enzymes, and monoclonal antibodies, supporting the development of novel biologic drugs.

A focused set of recombinant immune regulatory proteins, such as PD-1, PD-L1, and CTLA-4, essential for research and drug discovery in cancer immunotherapy and autoimmunity.

A recombinant B-lymphocyte surface antigen, CD19, which is a pivotal target for immunotherapy in B-cell malignancies, including CAR-T cell and antibody-based therapies.

A wide array of recombinant human and animal cytokines, chemokines, and interferons for studying immune responses, inflammation, hematopoiesis, and cell communication.

Recombinant proteins specifically relevant as E3 ligases or target proteins for Proteolysis Targeting Chimeras (PROTACs), enabling the development of this novel targeted protein degradation technology.